ReviewCancers2025

Surgical Outcomes After Neoadjuvant Chemo-Immunotherapy for Stage III NSCLC: A Systematic Review and Meta-Analysis.

Claudia Bardoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.